Atlas Trials

ADVM-022 Intravitreal Gene Therapy for Wet AMD

Clinical trial NCT03748784 · COMPLETED

Trial details

NCT number
NCT03748784
Sponsor
Adverum Biotechnologies, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Start date
2018-11-14
Primary completion
2022-06-22
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.